Benchmark Botanics Stock Gross Profit
| BHHKF Stock | USD 0 0.00 0.00% |
Benchmark Botanics fundamentals help investors to digest information that contributes to Benchmark Botanics' financial success or failures. It also enables traders to predict the movement of Benchmark Pink Sheet. The fundamental analysis module provides a way to measure Benchmark Botanics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Benchmark Botanics pink sheet.
Benchmark |
Benchmark Botanics Company Gross Profit Analysis
Benchmark Botanics' Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.
Current Benchmark Botanics Gross Profit | (62.33 K) |
Most of Benchmark Botanics' fundamental indicators, such as Gross Profit, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Benchmark Botanics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.
| Competition |
According to the company disclosure, Benchmark Botanics reported (62,325) of gross profit. This is 100.0% lower than that of the Healthcare sector and significantly lower than that of the Drug Manufacturers—Specialty & Generic industry. The gross profit for all United States stocks is 100.0% higher than that of the company.
Did you try this?
Run Fundamentals Comparison Now
Fundamentals ComparisonCompare fundamentals across multiple equities to find investing opportunities |
| All Next | Launch Module |
Benchmark Fundamentals
| Return On Equity | -11.56 | |||
| Return On Asset | -0.21 | |||
| Operating Margin | (18.13) % | |||
| Current Valuation | 6.45 M | |||
| Shares Outstanding | 58.99 M | |||
| Price To Book | 0.88 X | |||
| Price To Sales | 4.61 X | |||
| Revenue | 1.01 M | |||
| Gross Profit | (62.33 K) | |||
| EBITDA | (12.61 M) | |||
| Net Income | (10.06 M) | |||
| Cash And Equivalents | 273.03 K | |||
| Total Debt | 8.08 M | |||
| Debt To Equity | 1.50 % | |||
| Current Ratio | 0.13 X | |||
| Book Value Per Share | 0.01 X | |||
| Cash Flow From Operations | (2.73 M) | |||
| Earnings Per Share | (0.39) X | |||
| Beta | 0.99 | |||
| Market Capitalization | 1.75 M | |||
| Total Asset | 6.52 M | |||
| Z Score | -3.3 | |||
| Net Asset | 6.52 M |
About Benchmark Botanics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Benchmark Botanics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Benchmark Botanics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Benchmark Botanics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Benchmark Pink Sheet
Benchmark Botanics financial ratios help investors to determine whether Benchmark Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Benchmark with respect to the benefits of owning Benchmark Botanics security.